A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Conditions
Atopic Dermatitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hamilton Research, LLC, Alpharetta, Georgia, United States
Revival Research Institute, LLC, Troy, Michigan, United States
Best Skin Research LLC, Camp Hill, Pennsylvania, United States
Centro de Estudos em Terapias Inovadoras ? CETI, Curitiba, Paraná, Brazil
Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Clnicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu, Botucatu, São Paulo, Brazil
Centro de Pesquisa São Lucas, Campinas, São Paulo, Brazil
HMCG - Hospital e Maternidade Dr. Christovo da Gama, Santo Andr, São Paulo, Brazil
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, Sao Jose Rio Preto, São Paulo, Brazil
Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A, Rio de Janeiro, Brazil
DermEffects, London, Ontario, Canada
Lynderm Research Inc, Markham, Ontario, Canada
DermEdge, Mississauga, Ontario, Canada
Ryan Clinical Research Inc, Newmarket, Ontario, Canada
Fachklinik Bad Bentheim, Bad Bentheim, Lower Saxony, Germany
Dermatologikum Hamburg Gemeinschaftspraxis GbR, Hamburg, Germany
Centrum Medyczne Pratia Katowice I, Katowice, Silesian Voivodeship, Poland
Centrum Medyczne Pratia Gdynia, Gdynia, Poland
Specjalistyczny Gabinet Dermatologiczny dr n. med. Pawel Brzewski, Krakow, Poland
Centrum Nowoczesnych Terapii "Dobry Lekarz", Krakow, Poland
Uniwersytecki Szpital Kliniczny im.Fryderyka Chopina w Rzeszowie, Rzeszów, Poland
Klinika Ambroziak Dermatologia, Warsaw, Poland
Hospital Universitario Reina Sofia, Córdoba, Spain
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche